The study by Zhang et al. suggests that S100A12 can be elevated within 2 h after the onset of symptoms in ST-segment elevation myocardial infarction (STEMI), and that S100A12 can diagnose STEMI more quickly compared to other biomarkers [22]. Here, S100A12 is linked to ST Elevation Myocardial Infarction.